EUROCELL PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.5 GBX | -0.37% |
|
-0.37% | +2.67% |
| Mar. 27 | Prudential Chair Shriti Vadera buys 50,000 shares | AN |
| Mar. 22 | Transcript : Eurocell plc, 2023 Earnings Call, Mar 22, 2024 |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The stock, which is currently worth 2024 to 0.58 times its sales, is clearly overvalued in comparison with peers.
- This company will be of major interest to investors in search of a high dividend stock.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Construction Supplies & Fixtures
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +2.67% | 185M | C | ||
| +56.72% | 2.92B | B+ | ||
| +0.85% | 1.64B | C+ | ||
| +3.79% | 1.11B | - | - | |
| +21.54% | 789M | - | - | |
| +3.25% | 738M | B- | ||
| -21.12% | 572M | - | ||
| +50.18% | 528M | - | - | |
| -14.58% | 507M | - | ||
| -5.47% | 337M | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- ECEL Stock
- Ratings Eurocell plc